|
|
| Line 1: |
Line 1: |
| __NOTOC__
| | #REDIRECT [[Bisoprolol]] |
| {{Bisoprolol}}
| |
| {{CMG}}; {{AE}} {{SS}}
| |
| | |
| '''''For patient information about Bisoprolol, click [[Bisoprolol (patient information)|here]]'''''
| |
| | |
| {{SB}} ZEBETA<sup>®</sup>
| |
| | |
| ==Overview==
| |
| '''Bisoprolol''' is a drug belonging to the group of [[beta blocker]]s, a class of drugs used primarily in [[cardiovascular disease]]s. More specifically, it is a selective type β1 [[adrenergic receptor]] blocker <ref>[http://www.fass.se/LIF/produktfakta/artikel_produkt.jsp?NplID=20040326000029&DocTypeID=7&UserTypeID=2 FASS (Swedish official drug catalog) (labeling as "Selektiv beta1-blockerare" = selective beta1-blocker)]</ref>.
| |
| ==Category==
| |
| Cardiovascular Drugs：Beta blockers
| |
| ==FDA Package Insert==
| |
| | |
| '''| [[Bisoprolol indications and usage|Indications and Usage]]'''
| |
| '''| [[Bisoprolol dosage and administration|Dosage and Administration]]'''
| |
| '''| [[Bisoprolol contraindications|Contraindications]]'''
| |
| '''| [[Bisoprolol warnings and precautions|Warnings and Precautions]]'''
| |
| '''| [[Bisoprolol adverse reactions|Adverse Reactions]]'''
| |
| '''| [[Bisoprolol drug interactions|Drug Interactions]]'''
| |
| '''| [[Bisoprolol use in specific populations|Use in Specific Populations]]'''
| |
| '''| [[Bisoprolol overdosage|Overdosage]]'''
| |
| '''| [[Bisoprolol description|Description]]'''
| |
| '''| [[Bisoprolol clinical pharmacology|Clinical Pharmacology]]'''
| |
| '''| [[Bisoprolol nonclinical toxicology|Nonclinical Toxicology]]'''
| |
| '''| [[Bisoprolol clinical studies|Clinical Studies]]'''
| |
| '''| [[Bisoprolol how supplied storage and handling|How Supplied/Storage and Handling]]'''
| |
| '''| [[Bisoprolol patient counseling information|Patient Counseling Information]]'''
| |
| '''| [[Bisoprolol labels and packages|Labels and Packages]]'''
| |
| | |
| ==Mechanism of Action==
| |
| | |
| The mechanism of action of its antihypertensive effects has not been completely established. Factors which may be involved include:
| |
| | |
| *Decreased cardiac output,
| |
| *Inhibition of renin release by the kidneys,
| |
| *Diminution of tonic sympathetic outflow from the vasomotor centers in the brain.
| |
| ==References==
| |
| | |
| {{Reflist|2}}
| |
| | |
| [[Category:Beta blockers]]
| |
| [[Category:Cardiovascular Drugs]]
| |
| [[Category:Drugs]]
| |
| {{WikiDoc Help Menu}}
| |
| {{WikiDoc Sources}}
| |
| | |
| | |
| [[de:Bisoprolol]]
| |
| [[hr:Bisoprolol]]
| |
| [[hu:Bizoprolol]]
| |
| [[nl:Bisoprolol]]
| |
| [[ru:Бисопролол]]
| |